Frontiers in Endocrinology (Dec 2024)
Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial
Abstract
No abstracts available.Keywords
Frontiers in Endocrinology (Dec 2024)